PDCD1 and cancer: Upon PD‐1–PD‐L1 binding, negative regulatory signals are transmitted to T cells, leading to failure in recognizing cancer cells and allowing immune escape.[73] Blocking PD‐1–PD‐L1 binding can activate T cells and result in the elimination of cancer cells.